SMC accepts restricted use of rivaroxaban for CAD
The SMC has approved a drug, called rivaroxaban, that targets Factor Xa to treat those with coronary artery disease (CAD)...
List view / Grid view
News
Phase III clinical trial for treatment of dry eye syndrome
A Phase III trial looks to treat dry eye syndrome using a sterile, preservative-free eye drop formulation that has thymosin beta 4 as its active ingredient...
Health Canada issues NOC/c for oral myeloid leukaemia therapy
Health Canada has issued a Notice of Compliance with conditions for the first oral drug for acute myeloid leukaemia, a rapidly progressing condition...
Following FMD rulings using a ‘pragmatic’ approach
The falsified medicines directive (FMD) has finally kicked in, but how will the UK supply chain be affected, and how will pharmacies and hospitals cope?
Method for improving infrared imaging performance
Researchers have identified a method of improving the performance of infrared imaging techniques which could be useful in medical applications...
NICE and Canadian Agency collaborate to offer parallel scientific advice
NICE in the UK and its counterpart - the Canadian Agency for Drugs and Technology in Health have collaborated to offer parallel scientific advice...
FDA launches pilot programme to track and trace US supply chain
The pilot project will test innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the US...
Compressed injection pill for oral insulin delivery
A compressed injection pill could be the future alternative to injections of insulin delivery for patients with type 2 diabetes...
Pharmapack Europe award winners 2019 – 22 years of innovation
Innovations across drug delivery devices, dosage packaging, and materials and components bestowed in the Exhibitor Innovation Category...
Microbiological considerations in cleanroom validation
Wickham Laboratories Ltd is delighted to announce our most recent technical article on, “microbiological considerations in cleanroom validation”, which has been featured in European Pharmaceutical Review’s December 2018 issue...
Omadacycline similar to commonly-used antibiotics for treating pneumonia, skin infections
Findings of two phase III, double-blind, randomised clinical trials comparing omadacycline with standard antibiotics have been published in the New England Journal of Medicine
Combination antiplatelet therapy reduces risk of recurrent stroke
A combination therapy using the blood thinner cilostazol, along with either aspirin or clopidogrel, was shown to decrease the risk of stroke recurrence...
FDA approval for Cablivi to treat rare clotting disorder
The FDA has approved the first specific therapy for the rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP)...
Researchers launch virtual docking library to aid drug discovery
Researchers have launched a large virtual docking library expected to grow to more than one billion molecules by 2020 which could aid drug discovery...
PDA Italy Chapter has chosen the new COO of PQE Group, Claudio Puglisi, as member of the executive committee for the role of Chapter Liaison and External Relationship
The counting of votes that saw the election of Mr. Claudio Puglisi, new COO of PQE Group, was held last January 31st in Milan, Italy...
